Wells Fargo has delivered 18 consecutive earnings beats and 11% Y/Y EPS growth, signaling operational consistency and ...
Wells Fargo & Company reiterated their equal weight rating on shares of Bausch + Lomb (NYSE:BLCO – Free Report) in a report issued on Friday morning, MarketBeat.com reports. They currently have a $15.
Here are some of the top stories moving markets midday Friday. The "Magnificent Seven" are part of the reason stocks are ...
Bausch + Lomb (NYSE:BLCO) stock falls as the company's voluntary recall of enVista lenses leads to a downgrade at Wells Fargo ...
Deutsche Bank slashed the price target for Tesla, Inc. TSLA from $420 to $345. Deutsche Bank analyst Edison Yu maintained a ...
Investing.com -- Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh ...
Fintel reports that on March 28, 2025, Wells Fargo downgraded their outlook for Bausch + Lomb (NYSE:BLCO) from Overweight to ...
Investors looked ahead to the latest reading of the personal consumption expenditures price index, due on Friday.
Investors looked ahead to the latest reading of the personal consumption expenditures price index, due on Friday.